Fauchet R - Search Results

1

Multifactorial drug-resistance phenomenon in acute leukemias: impact of P170-MDR1, LRP56 protein, glutathione-transferases and metallothionein systems on clinical outcome.

Goasguen JE, Lamy T, Bergeron C, Ly Sunaram B, Mordelet E, Gorre G, Dossot JM, Le Gall E, Grosbois B, Le Prisé PY, Fauchet R. Goasguen JE, et al. Among authors: fauchet r. Leuk Lymphoma. 1996 Nov;23(5-6):567-76. doi: 10.3109/10428199609054866. Leuk Lymphoma. 1996. PMID: 9031088

2

P-glycoprotein (P-170) and CD34 expression in adult acute myeloid leukemia (AML).

Lamy T, Goasguen JE, Mordelet E, Grulois I, Dauriac C, Drenou B, Chaperon J, Fauchet R, le Prise PY. Lamy T, et al. Among authors: fauchet r. Leukemia. 1994 Nov;8(11):1879-83. Leukemia. 1994. PMID: 7526090

3

Multi-drug resistance (MDR) activity in acute leukemia determined by rhodamine 123 efflux assay.

Lamy T, Drenou B, Grulois I, Fardel O, Jacquelinet C, Goasguen J, Dauriac C, Amiot L, Bernard M, Fauchet R, et al. Lamy T, et al. Among authors: fauchet r. Leukemia. 1995 Sep;9(9):1549-55. Leukemia. 1995. PMID: 7658724

4

Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications.

Goasguen JE, Dossot JM, Fardel O, Le Mee F, Le Gall E, Leblay R, LePrise PY, Chaperon J, Fauchet R. Goasguen JE, et al. Among authors: fauchet r. Blood. 1993 May 1;81(9):2394-8. Blood. 1993. PMID: 8097634 Free article.

5

Multidrug resistance in aggressive lymphoproliferative disorders of T and natural-killer origin.

Drénou B, Amiot L, Lamy T, Le Prisé PY, Fauchet R. Drénou B, et al. Among authors: fauchet r. Leuk Lymphoma. 1998 Jul;30(3-4):381-7. doi: 10.3109/10428199809057549. Leuk Lymphoma. 1998. PMID: 9713968

6

Effects of clinical combinations of antileukemic drugs on DNA ligase from human thymocytes and normal, stimulated, or leukemic lymphocytes.

Lamballe F, Maniey D, Boscher MY, Fauchet R, le Prise PY, David JC. Lamballe F, et al. Among authors: fauchet r. Leukemia. 1988 Jun;2(6):363-70. Leukemia. 1988. PMID: 3259660

7

Multidrug resistance in B-cell chronic lymphocytic leukemia.

Grulois I, Fardel O, Drenou B, Lamy T, Le Prisé PY, Fauchet R. Grulois I, et al. Among authors: fauchet r. Acta Haematol. 1995;94(2):78-83. doi: 10.1159/000203978. Acta Haematol. 1995. PMID: 7484017

8

Inhibition of P-glycoprotein activity in human leukemic cells by mifepristone.

Fardel O, Courtois A, Drenou B, Lamy T, Lecureur V, le Prisé PY, Fauchet R. Fardel O, et al. Among authors: fauchet r. Anticancer Drugs. 1996 Aug;7(6):671-7. doi: 10.1097/00001813-199608000-00008. Anticancer Drugs. 1996. PMID: 8913436

9

CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance.

Drénou B, Lamy T, Amiot L, Fardel O, Caulet-Maugendre S, Sasportes M, Diebold J, Le Prisé PY, Fauchet R. Drénou B, et al. Among authors: fauchet r. Blood. 1997 Apr 15;89(8):2966-74. Blood. 1997. PMID: 9108417 Free article.

10

Loss of HLA molecules in B lymphomas is associated with an aggressive clinical course.

Amiot L, Onno M, Lamy T, Dauriac C, Le Prise PY, Fauchet R, Drenou B. Amiot L, et al. Among authors: fauchet r. Br J Haematol. 1998 Mar;100(4):655-63. doi: 10.1046/j.1365-2141.1998.00631.x. Br J Haematol. 1998. PMID: 9531330 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

225 results

Search Page

Filters